Friday, November 20, 2020

Limited access to buprenorphine restricts resident physicians treating opioid abusers

A survey of resident physicians in Florida indicates they are interested in treating opioid addiction but face barriers to offering patients treatment using buprenorphine, an FDA-approved medication shown to successfully decrease opioid use, overdose events, and deaths associated with opioids.